NCT03238274View on ClinicalTrials.gov

Sofia 2 Lyme FIA Whole Blood Clinical Study

CompletedOBSERVATIONAL
Enrollment

597

Participants

Timeline

Start Date

June 6, 2017

Primary Completion Date

December 15, 2017

Study Completion Date

December 15, 2017

Conditions
Borrelia; Infection, Burgdorferi (Erythema Chronicum Migrans)
Interventions
DEVICE

Sofia 2 Lyme FIA testing

IVD testing of whole blood or serum/plasma to aid in the detection of anti-B. burgdorferi IgG / IgM antibody

Trial Locations (11)

13760

Regional Clinical Research, Endwell

16635

Altoona Center for Clinical Research, Duncansville

19438

Harleysville Medical Associates, Harleysville

54449

Marshfield Clinic Research Institute, Marshfield

55805

Essentia Institute of Rural Health, Duluth

02721

NECCR Primacare Research, LLC, Fall River

02790

Main Road Family Medicine, South Westport

02865

Lincoln Primary Care, Lincoln

02906

The Miriam Hospital, Providence

02908

Center for Medical Research, LLC, Providence

02891

Ocean State Primary Care, Westerly

All Listed Sponsors
lead

Quidel Corporation

INDUSTRY

NCT03238274 - Sofia 2 Lyme FIA Whole Blood Clinical Study | Biotech Hunter | Biotech Hunter